Defining NF1 clinical variation at the microscale to discover new therapeutic targets

Ellisdon, Andrew (Primary Chief Investigator (PCI))
Halls, Michelle (Chief Investigator (CI))
Schittenhelm, Ralf (Chief Investigator (CI))
Morand, Eric (Associate Investigator (AI))
Whisstock, James (Associate Investigator (AI))
Sloan, Erica (Associate Investigator (AI))

Project: Research

Status	Active
Effective start/end date	1/06/21 → 31/05/24

1 Article

The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1
Lupton, C. J., Bayly-Jones, C., D’Andrea, L., Huang, C., Schittenhelm, R. B., Venugopal, H., Whisstock, J. C., Halls, M. L. & Ellisdon, A. M., Dec 2021, In: Nature Structural & Molecular Biology. 28, 12, p. 982-988 7 p.
Research output: Contribution to journal › Article › Research › peer-review

14 Citations (Scopus)

Monash Proteomics & Metabolomics Facility
Ralf Schittenhelm (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility